Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Binge Eating Disorder Therapy Pipeline Review, H2 2017 - Research and Markets

Research and Markets
Posted on: 19 Dec 17

The "Binge Eating Disorder - Pipeline Review, H2 2017" report has been added to Research and Markets' offering.

Binge Eating Disorder - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Binge Eating Disorder (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Binge Eating Disorder (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Binge Eating Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II and Preclinical stages are 1, 2, 2 and 6 respectively.

Binge Eating Disorder (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Binge Eating Disorder - Overview
  2. Binge Eating Disorder - Therapeutics Development
  3. Pipeline Overview
  4. Pipeline by Companies
  5. Products under Development by Companies
  6. Binge Eating Disorder - Therapeutics Assessment
  7. Assessment by Target
  8. Assessment by Mechanism of Action
  9. Assessment by Route of Administration
  10. Assessment by Molecule Type
  11. Binge Eating Disorder - Companies Involved in Therapeutics Development
  • Chronos Therapeutics Ltd
  • F. Hoffmann-La Roche Ltd
  • Heptares Therapeutics Ltd
  • Highland Therapeutics Inc
  • India Globalization Capital Inc
  • Novo Nordisk AS
  • Omeros Corp
  • Opiant Pharmaceuticals Inc
  • Shire Plc
  • Sunovion Pharmaceuticals Inc

For more information about this report visit

View source version on

Business Wire

Last updated on: 19/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.